TP53 and colorectal carcinoma: The experimental proofs obtained both in vitro and in vivo allowed to establish a model, in which the presence of TP53 mutations in CRC cells, specifically resulting in a gain of function (mutp53), led to an increase of miR-1246 levels in exosomes [111].